These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17538420)

  • 1. Why use erythromycin to manage gastroparesis?
    King JE
    Nursing; 2007 Jun; 37(6):20. PubMed ID: 17538420
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
    Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
    J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis.
    Takanashi H; Cynshi O
    Regul Pept; 2009 Jun; 155(1-3):18-23. PubMed ID: 19345243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic gastroparesis.
    Kong MF; Horowitz M
    Diabet Med; 2005 Sep; 22 Suppl 4():13-8. PubMed ID: 16109013
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythromycin and gastroparesis? Off-licence use: uncertain efficacy for a poorly defined disorder.
    Prescrire Int; 1999 Feb; 8(39):13-5. PubMed ID: 10557568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
    Janssen P; Harris MS; Jones M; Masaoka T; Farré R; Törnblom H; Van Oudenhove L; Simrén M; Tack J
    Am J Gastroenterol; 2013 Sep; 108(9):1382-91. PubMed ID: 24005344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic gastroparesis.
    Maderazo EG
    N Engl J Med; 2007 Jul; 357(4):418-9; author reply 419-20. PubMed ID: 17663031
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.
    Ishii M; Nakamura T; Kasai F; Baba T; Takebe K
    Diabetes Care; 1997 Jul; 20(7):1134-7. PubMed ID: 9203450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric emptying and prokinetics.
    Hegde R
    Intensive Care Med; 1997 Aug; 23(8):928. PubMed ID: 9310822
    [No Abstract]   [Full Text] [Related]  

  • 11. The riddle, mystery, and enigma of gastroparesis.
    Pasricha PJ
    J Support Oncol; 2007 Sep; 5(8):368-70. PubMed ID: 17944145
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: The diagnosis and management of gastroparesis.
    Haans JJ; Masclee AA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroparesis after retroperitoneal surgery successfully treated with erythromycin.
    Heidenreich A; Wille S; Hofmann R
    J Urol; 2000 Feb; 163(2):545. PubMed ID: 10647677
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of long-term, low-dose erythromycin in treating persistent gastric stasis.
    Hunter A; Regnard C; Armstrong C
    J Pain Symptom Manage; 2005 May; 29(5):430-3. PubMed ID: 15904744
    [No Abstract]   [Full Text] [Related]  

  • 15. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severely delayed gastric emptying].
    Samsom M; Gooszen HG
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1945-8. PubMed ID: 11048557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
    Talley NJ; Verlinden M; Geenen DJ; Hogan RB; Riff D; McCallum RW; Mack RJ
    Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of dopamine D3 and neuropeptide Y Y5 receptors in diabetic gastroparetic rats without response to erythromycin.
    Qin XY; Wang ZG; Fei J; Liu FL; Cui DF; Chen SL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):811-5. PubMed ID: 12958653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between symptom improvement and gastric emptying in the treatment of gastroparesis: remember the pharmacology.
    Sanger GJ
    Am J Gastroenterol; 2014 Mar; 109(3):444-5. PubMed ID: 24594956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.